1. Recent advances of antitumor shikonin/alkannin derivatives: A comprehensive overview focusing on structural classification, synthetic approaches, and mechanisms of action
   Mehdi Valipour, 2022, European Journal of Medicinal Chemistry CrossRef
2. Exosomes: A novel insight into traditional Chinese medicine
   Chao Mo et al, 2022, Front. Pharmacol. CrossRef
3. FOXP3+ regulatory T cells and the immune escape in solid tumours
   Yiran Qiu et al, 2022, Front. Immunol. CrossRef
4. Immunomodulatory role of metalloproteinase ADAM17 in tumor development
   Kai Wang et al, 2022, Front. Immunol. CrossRef
5. Machine learning-based glycolysis-associated molecular classification reveals differences in prognosis, TME, and immunotherapy for colorectal cancer patients
   Zhenling Wang et al, 2023, Front. Immunol. CrossRef
6. Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation.
   Xinyu Qian et al, 2023, Chem Biol Interact CrossRef
7. Different Roles of Apoptosis and Autophagy in the Development of Human Colorectal Cancer
   Giulia Orlandi et al, 2023, IJMS CrossRef
8. E2F3 accelerates the stemness of colon cancer cells by activating the STAT3 pathway
   Qingkun Gao et al, 2023, Front. Oncol. CrossRef
9. Exploring Cancer Dependency Map genes and immune subtypes in colon cancer, in which TIGD1 contributes to colon cancer progression
   Guoyang Zhang et al, 2023, Aging CrossRef
10. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in colorectal cancer
    Ying Li et al, 2023, J Cancer Res Clin Oncol CrossRef
11. Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties
    Eduardo Angulo-Elizari et al, 2024, European Journal of Medicinal Chemistry CrossRef
12. Sulforaphane Inhibits IL-1β-Induced IL-6 by Suppressing ROS Production, AP-1, and STAT3 in Colorectal Cancer HT-29 Cells
    Dhiraj Kumar Sah et al, 2024, Antioxidants CrossRef
13. Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches
    Rohitas Deshmukh et al, 2024, CPB CrossRef
14. Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation
    Min Wang et al, 2024, J Ovarian Res CrossRef
15. Systematic bioinformatics analysis reveals the role of shikonin in blocking colon cancer progression by identifying senescence-induced genes
    Wenna Liu et al, 2024, Front. Pharmacol. CrossRef
16. Shikonin induces the apoptosis and pyroptosis of EGFR-T790M-mutant drug-resistant non-small cell lung cancer cells via the degradation of cyclooxygenase-2
    Shaoyi Cao et al, 2024, Eur J Med Res CrossRef
17. Priming immunity via herbal components and their nanomedicines for the treatment of cancer
    Xiang Li et al, 2024 CrossRef